Jefferies & Co initiates coverage on ev3 Inc. (EVVV) with a Buy
More News related to EVVV
- Don't Miss Out! The Registration Period for the 2010 IR Global Rankings Ends TOMORROW!
- Time Is Running Out to Have Your IR Program Independently Evaluated!
- Canaccord Adams Reiterates a 'Buy' on ev3 (EVVV); Management Team Continues to Execute
- ev3 Inc. (EVVV) Reports Q3 EPS of $0.06; Guides
- ev3 Reports 2009 Third Quarter Financial Results
More News related to New Coverage
- Morgan Stanley Initiates Coverage on Williams Companies (WMB) with an Overweight
- Morgan Stanley Starts ONEOK (OKE) at Underweight, $40 Price Target
- Broadpoint.Amtech Initiates Coverage on Willbros Group (WG) with a Buy; Leading North American Pipeline Contractor
- Miller Tabak Initiates Coverage on Oclaro (OCLR) with a Buy
- Natixis Bleichroeder Initiates Coverage on Gen-Probe (GPRO) with a Buy
Jefferies & Co initiates coverage on ev3 Inc. (Nasdaq: EVVV) with a Buy, citing positive growth outlook and business opportunities. Price target $15
ev3 Inc. (ev3) is a global medical device company focused on catheter-based technologies for the endovascular treatment of vascular diseases and disorders.
Related Categories
New CoverageStocks Mentioned
+0.07Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
